Investigative Site: #79

Rostov-on-Don 603024

0 studies enrolling now · 1 studies all time

What they study most

KRAS Positive Patients With Non-small Cell Lung Cancer, Squamous Cell Non-small Cell Lung Cancer

Studies at this site

• A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung Cancer — Completed